billion last month it reached the highest level for february since records began almost 30 years ago. a warning that poor oral health is still a significant problem in england despite being largely preventable. and coming up this hour. a big day forjockey rachael blackmore she s leading the way at the cheltenham festival, and could be the first woman to win the gold cup. our top story, this morning. the prime minister is due to receive the oxford astrazeneca vaccine today and has assured the public it is safe. it s after several leading european countries have confirmed they are to resume the rollout of the jab following a pause over safety concerns. borisjohnson s urged people to get vaccinated and says england s roadmap out of lockdown is on track, despite a drop in vaccine supply. the roll out of the oxford astrazeneca vaccine will resume in some eu countries today, after regulators found no evidence it causes blood clots. the european medicines agency reviewed the
against alex salmond say the first minister misled them while giving evidence this month. sharp words exchanged at the first high level meeting between america s new presidential administration and china. and coming up this hour. as part of our young reporter series, we hearfrom an apprentice footballer about the pressures of trying to make it as a professional. hello and welcome if you re watching in the uk or around the world. germany s health minister has warned there is not enough coronavirus vaccine to stop a third wave in europe. germany is facing further restrictions because the number of cases are rising rapidly. some eu countries including germany will resume the roll out of the astrazeneca jab today, following a pause over safety concerns. the european medicines agency reviewed the jab and found that it was not associated with a higher risk of blood clots. france, germany and italy, along with cyprus, latvia and lithuania, are to restart use of the jab today w
sunday. welcome to our viewers on pbs in america and around the globe. in the past hour spain hasjoined france, germany and italy to become the latest countries to suspend use of the oxford astrazeneca jab. it s over concerns about blood clots. this is happening despite the who saying there is no indication of a link between the vaccine and blood clots. earlier, the republic of ireland and netherlands made a similar decision. it means eleven european nations in total have paused their rollout of the vaccination. some european countries have stopped using certain batches of the drug as a precautionary measure. the european medicines agency is carrying out a review into incidents of blood clots. it says the vaccine s benefits continue to outweigh its risks, and that it will hold an extraordinary meeting on the vaccine on thursday. around 17 million people in the european union and the uk have received a dose of the vaccine, with fewer than than a0 cases of blood clots reported.
the reputation of the vaccine. several european countries initially restricted the use of the astrazeneca jab, following a scare about rare blood clots. the vaccine has not played a significant role in the booster campaign. 0ur medical editor fergus walsh reports. cheering the roll out of the oxford/astrazeneca vaccine in the uk is widely regarded as a great success, but in the eu, it was beset by hurdles. in late january 2021, with vaccines in desperately short supply, president macron described the astrazeneca jab as quasi ineffective in the elderly. france and germany said they wouldn t use it for older adults, but both reversed that decision weeks later when it was shown to be highly protective. many eu countries briefly suspended its use completely over the risk of rare blood clots. a few never used it again.
to cross the us canada border, but the protests have grown into broader challenges to covid health restrictions. its ambition was to be a vaccine for the world two and a half billion doses of the oxford astrazeneca jab were delivered across the globe during the pandemic and nearly half of all adults in the uk received two doses of it. its use in the rest of europe, though, wasn t straightforward. there was a row with the eu about supply shortages and restrictions were put on the vaccine s use over the risk of rare blood clots. so did politics get in the way? our medical editor fergus walsh reports. cheering. the roll out of the oxford astrazeneca vaccine in the uk is widely regarded as a great success, but, in the eu, it was beset by hurdles. in late january 2021, with vaccines in desperately short supply, president macron described the astrazeneca jab as quasi ineffective in the elderly.